G Medical Innovations is engaged in the development of next generation mobile technologies that will provide consumers, patients and healthcare providers to better monitor, manage and improve clinical and personal health outcomes. Co. also focusing in developing mobile embedded medical sensors and providing remote patient monitoring services. Co.'s segments include: Products segment, which is engaged in development, manufacture and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market; and Patient services segment, which includes cardiac monitoring services of MCT, Patch, Event, Holter, Extended Holter and Pacemaker. The GMVD average annual return since 2021 is shown above.
The Average Annual Return on the GMVD average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether GMVD average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the GMVD average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|